Nivolumab for treating recurrent or metastatic squamous cell carcinoma of the head and neck after platinum-based chemotherapy

Supporting evidence

• Evaluation report

• Final appraisal determination committee papers (PDF 1.9 MB)

  Published:

  20 October 2021

• Appraisal consultation committee papers (PDF 3.58 MB)

  Published:

  20 October 2021